| editorial | Q871232 |
| scholarly article | Q13442814 |
| P2093 | author name string | Xianlin Han | |
| Linlin Zhang | |||
| Xiangdong Wang | |||
| P2860 | cites work | Clinical trans-omics: an integration of clinical phenomes with molecular multiomics | Q88462911 |
| Lipidomics for studying metabolism | Q28802472 | ||
| Principles and practice of lipidomics | Q35437430 | ||
| Recent advances in lipidomics for disease research | Q38591116 | ||
| Critical roles of mucin-1 in sensitivity of lung cancer cells to tumor necrosis factor-alpha and dexamethasone | Q38687877 | ||
| Lipidomics: Techniques, Applications, and Outcomes Related to Biomedical Sciences | Q38803730 | ||
| Progress and challenges of sequencing and analyzing circulating tumor cells | Q47425176 | ||
| Lipidomics Analysis of Behavioral Variant Frontotemporal Dementia: A Scope for Biomarker Development. | Q52655246 | ||
| Lipidomics. | Q53668058 | ||
| Clinical lipidomics: a new way to diagnose human diseases. | Q55193014 | ||
| Heterogeneity of lipidomic profiles among lung cancer subtypes of patients. | Q64891799 | ||
| New biomarkers and therapeutics can be discovered during COPD-lung cancer transition | Q87876801 | ||
| P2507 | corrigendum / erratum | Correction to: Is the clinical lipidomics a potential goldmine? | Q93002730 |
| P433 | issue | 6 | |
| P304 | page(s) | 421-423 | |
| P577 | publication date | 2018-07-21 | |
| P1433 | published in | Cell Biology and Toxicology | Q2225254 |
| P1476 | title | Is the clinical lipidomics a potential goldmine? | |
| P478 | volume | 34 |
| Q96167200 | Molecular regulation and clinical significance of caveolin-1 methylation in chronic lung diseases |
| Q64271641 | Values of integration between lipidomics and clinical phenomes in patients with acute lung infection, pulmonary embolism, or acute exacerbation of chronic pulmonary diseases: a preliminary study |
| Q93002730 | Correction to: Is the clinical lipidomics a potential goldmine? | main subject | P921 |
Search more.